Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxypropyl guar polymer chain is a synthetic derivative of guar gum, a natural polysaccharide (galactomannan) extracted from the seeds of *Cyamopsis tetragonoloba* (guar plant). The structure consists of a backbone of β-(1→4)-linked D-mannopyranosyl units, with side chains of α-(1→6)-linked D-galactopyranosyl residues, and is further chemically modified through hydroxypropylation (introduction of propylene glycol ether groups) at some of the hydroxyl sites[2][3]. This chemical modification markedly enhances water solubility, viscosity, and stability properties compared to native guar gum, enabling its use across industrial sectors such as food, cosmetics, pharmaceuticals, and oilfield applications as a thickener, stabilizer, and binder[4][6]. Hydroxypropyl guar is not associated with direct biological activities in human physiology or pathology, and is not considered a therapeutic biochemical target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxypropyl guar polymer chain.